Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

407
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
407
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

557
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
557
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

533
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
533
Allergic Reactions02:06

Allergic Reactions

28.2K
Overview
28.2K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

417
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
417

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic Induction of Neutrophilic Inflammatory Programs by <i>Staphylococcus aureus</i> and Cigarette Smoke in Airway Epithelial Cells.

Immune network·2026
Same author

Diagnostic Role of Aspirin Challenge in NSAID-Exacerbated Respiratory Disease: A Prospective Single-Center Study in China.

Allergy, asthma & immunology research·2026
Same author

Clinical remission in allergy and clinical immunology practice: State of the art and World Allergy Organization (WAO) call to action.

The World Allergy Organization journal·2026
Same author

ADAM8 mediates eosinophil and neutrophil infiltration and tissue remodeling in chronic rhinosinusitis with nasal polyps.

The Journal of allergy and clinical immunology·2026
Same author

Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.

Allergy·2026
Same author

Generation and Differentiation of Human Olfactory Epithelial Organoids from Adult Stem Cells.

Journal of visualized experiments : JoVE·2026

Related Experiment Video

Updated: Aug 27, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.9K

Local Immunoglobulin E in nasal polyps: Role and modulation.

Yang Shen1, Nan Zhang2, Yucheng Yang1

  • 1Department of Otorhinolaryngology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Frontiers in Immunology
|September 26, 2022
PubMed
Summary

Local immunoglobulin E (IgE) is elevated in nasal polyps, driving type 2 inflammation regardless of allergy. This local IgE, triggered by allergens and microbes like Staphylococcus aureus, presents a promising therapeutic target for chronic rhinosinusitis with nasal polyps (CRSwNP).

Keywords:
Immunoglobulin EStaphylococcus aureusType2 inflammationlocal B cellnasal polyposis

More Related Videos

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

30.7K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.2K

Related Experiment Videos

Last Updated: Aug 27, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.9K
Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

30.7K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.2K

Area of Science:

  • Immunology
  • Otorhinolaryngology
  • Allergy and Clinical Immunology

Background:

  • Immunoglobulin E (IgE) is traditionally linked to allergic diseases like asthma and allergic rhinitis (AR).
  • Emerging evidence highlights the role of local IgE in airway inflammatory diseases, independent of allergic status.
  • Chronic rhinosinusitis with nasal polyps (CRSwNP) is a significant airway inflammatory condition where local IgE's role is increasingly recognized.

Purpose of the Study:

  • To review recent evidence on the role of local IgE in CRSwNP.
  • To discuss the characteristics, synthesis modulation, and function of local IgE in nasal polyps (NPs).
  • To explore local IgE as a therapeutic target for CRSwNP.

Main Methods:

  • Review of current scientific literature on local IgE in CRSwNP.
  • Analysis of studies investigating IgE levels, characteristics, and influencing factors in nasal polyps.
  • Examination of the mechanisms of IgE synthesis, including B cell activation and class switch recombination (CSR).

Main Results:

  • Local IgE levels are significantly elevated in nasal polyps, irrespective of serum IgE or atopic status.
  • Local IgE correlates with type 2 inflammation, is polyclonal, and functionally active.
  • IgE production in polyps is triggered by allergens and microbial colonization (e.g., Staphylococcus aureus superantigen), involving B cell CSR.

Conclusions:

  • Local IgE plays a central role in the pathophysiology of CRSwNP.
  • Local IgE production is modulated by various immune cells, cytokines, and transcription factors.
  • Targeting local IgE has shown clinical success, highlighting its potential as a therapeutic strategy for nasal polyps.